Back
Byline Bancorp Vs. Dyne Therapeutics Industry Stock Comparison
Buy
64
BY
Byline Bancorp
Last Price:
23.18
Seasonality Move:
-1.65%
Buy
64
DYN
Dyne Therapeutics
Last Price:
35.41
Seasonality Move:
29.58%
Buy
64
Byline Bancorp (BY)
is a Buy
Is Byline Bancorp a Buy, Sell or Hold?
- The current Byline Bancorp [BY] share price is $22.98. The Score for BY is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
- BY is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
64
Dyne Therapeutics (DYN)
is a Buy
Is Dyne Therapeutics a Buy, Sell or Hold?
- The current Dyne Therapeutics [DYN] share price is $33.92. The Score for DYN is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
- DYN is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
BY Stock Price Chart
What is Byline Bancorp's stock price today?
-
The Byline Bancorp share price today is $22.98
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BY is experiencing buying pressure, which is a positive indicator for future bullish movement.
DYN Stock Price Chart
What is Dyne Therapeutics's stock price today?
-
The Dyne Therapeutics share price today is $33.92
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DYN is experiencing buying pressure, which is a positive indicator for future bullish movement.
BY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.02 | Buy |
Relative Strength Index (14 RSI): | 54.69 | Buy |
Chaikin Money Flow: | 96572 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (22.43 - 23.19) | Buy |
Bollinger Bands (100): | (20.52 - 22.84) | Buy |
DYN Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.3 | Buy |
Relative Strength Index (14 RSI): | 57.37 | Buy |
Chaikin Money Flow: | 599904 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (30.98 - 33.66) | Buy |
Bollinger Bands (100): | (23.98 - 30.96) | Buy |
BY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 22.73 | Buy |
20-day SMA: | 22.66 | Buy |
50-day SMA: | 22.56 | Buy |
200-day SMA: | 21.36 | Buy |
8-day EMA: | 22.75 | Buy |
20-day EMA: | 22.74 | Buy |
50-day EMA: | 22.49 | Buy |
200-day EMA: | 21.69 | Buy |
DYN Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 33.61 | Buy |
20-day SMA: | 32.56 | Buy |
50-day SMA: | 29.25 | Buy |
200-day SMA: | 19.48 | Buy |
8-day EMA: | 33.72 | Buy |
20-day EMA: | 32.57 | Buy |
50-day EMA: | 30.2 | Buy |
200-day EMA: | 22.36 | Buy |
Byline Bancorp Earnings Growth & BY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.01 per share, a decrease this year of $0.21 per share, and a decrease next year of $0.07 per share.
Dyne Therapeutics Earnings Growth & DYN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.05 per share, an increase this year of $0.77 per share, and an increase next year of $0.16 per share.
Byline Bancorp Technical Analysis
Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
12 | 13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Dyne Therapeutics Technical Analysis
Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
12 | 13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |